IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Acasti Pharma Inc

Q1 2026 vs Q2 2026

Comparing institutional holders between quarters

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Raelipskie Partnership
UNCHANGED
Shares2 from 2
Change0 (0%)
Value$5 (-$4)
Filed 2026-08-04
Status
Raelipskie Partnership
UNCHANGED2200%$9$5-$42026-08-04
Showing 1 of 1 institutions